HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

succinyl-coenzyme A (succinyl-CoA)

Also Known As:
succinyl-CoA; coenzyme A, S-(hydrogen butanedioate); coenzyme A, succinyl-
Networked: 90 relevant articles (3 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Fukao, Toshiyuki: 9 articles (01/2015 - 12/2004)
2. Kondo, Naomi: 6 articles (03/2013 - 12/2004)
3. Sass, Jörn Oliver: 4 articles (04/2021 - 05/2011)
4. Kursula, Petri: 3 articles (05/2011 - 11/2007)
5. Al-Hassnan, Zuhair N: 2 articles (11/2021 - 01/2018)
6. Yue, Wyatt W: 2 articles (04/2021 - 11/2013)
7. Hori, Tomohiro: 2 articles (01/2015 - 03/2013)
8. Takayanagi, Masaki: 2 articles (01/2015 - 12/2010)
9. Cotter, David G: 2 articles (07/2013 - 02/2013)
10. Crawford, Peter A: 2 articles (07/2013 - 02/2013)

Related Diseases

1. Anus Neoplasms (Anal Cancer)
2. Infections
3. Obesity
01/01/2023 - "Comment on Tabatabaei Dakhili et al. The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA Transferase. "
01/01/2023 - "The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA Transferase."
01/01/2023 - "Previous studies have demonstrated that elevations in skeletal muscle ketone oxidation contribute to obesity-related hyperglycemia, whereas inhibition of succinyl CoA:3-ketoacid CoA transferase (SCOT), the rate-limiting enzyme of ketone oxidation, can alleviate obesity-related hyperglycemia. "
01/01/2023 - "We have previously observed that elevated skeletal muscle succinyl CoA:3-ketoacid CoA transferase (SCOT) activity, the rate-limiting enzyme of ketone oxidation, contributes to the hyperglycemia characterizing obesity and T2D. "
01/01/2012 - "RT-PCR studies showed that ASP (like ELE with known anti-obesity effects) diminished isocitrate dehydrogenase 3α, NADH dehydrogenase flavoprotein 1 (Comp I) mRNA and fatty acid synthase levels (white adipose tissue), increased carnitine palmitoyltransferase 1α and acyl-CoA dehydrogenase, very-long-chain mRNA levels (liver), and increased Glut4, citrate synthase, isocitrate dehydrogenase 3α, succinyl CoA synthase, peroxisomal 3-ketoacyl-CoA thiolase, dihydrolipoamide succinyl transferase and succinate dehydrogenase mRNA levels (skeletal muscle) under HFD conditions. "
4. Starvation
5. Hyperglycemia

Related Drugs and Biologics

1. Vitamin B 12 (Cyanocobalamin)
2. Biomarkers (Surrogate Marker)
3. Succinic Acid (Succinate)
4. Fumarates
5. Transferases
6. Coenzyme A (CoA)
7. Enzymes
8. Ketones
9. Succinate Dehydrogenase (Fumarate Reductase)
10. Messenger RNA (mRNA)